Tudor Investment Corp ET AL Purchases New Holdings in Merit Medical Systems, Inc. $MMSI

Tudor Investment Corp ET AL acquired a new stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 35,000,000 shares of the medical instruments supplier’s stock, valued at approximately $2,913,050,000. Merit Medical Systems comprises 1.8% of Tudor Investment Corp ET AL’s portfolio, making the stock its 13th largest holding. Tudor Investment Corp ET AL owned approximately 0.59% of Merit Medical Systems as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in MMSI. Salomon & Ludwin LLC acquired a new position in shares of Merit Medical Systems in the third quarter valued at approximately $37,000. Danske Bank A S acquired a new stake in shares of Merit Medical Systems during the third quarter worth $42,000. Quarry LP grew its position in Merit Medical Systems by 185.9% in the 3rd quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock valued at $44,000 after buying an additional 342 shares during the last quarter. First Horizon Corp purchased a new position in Merit Medical Systems in the 3rd quarter valued at $78,000. Finally, EverSource Wealth Advisors LLC increased its stake in Merit Medical Systems by 745.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock valued at $86,000 after buying an additional 813 shares during the period. 99.66% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Robert W. Baird set a $108.00 target price on shares of Merit Medical Systems in a research note on Tuesday, December 16th. Needham & Company LLC dropped their price target on shares of Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating on the stock in a research note on Wednesday, February 25th. Piper Sandler cut their price target on shares of Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. Canaccord Genuity Group raised their price objective on shares of Merit Medical Systems from $93.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, December 17th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Merit Medical Systems in a report on Monday, December 29th. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Merit Medical Systems currently has an average rating of “Moderate Buy” and a consensus price target of $103.33.

Merit Medical Systems Price Performance

Merit Medical Systems stock opened at $68.27 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.95 and a current ratio of 4.34. Merit Medical Systems, Inc. has a one year low of $67.42 and a one year high of $107.27. The company has a market cap of $4.06 billion, a P/E ratio of 32.20, a price-to-earnings-growth ratio of 2.03 and a beta of 0.62. The business has a fifty day moving average of $79.08 and a two-hundred day moving average of $83.36.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.08. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The business had revenue of $393.94 million during the quarter, compared to the consensus estimate of $390.77 million. During the same quarter last year, the firm posted $0.93 EPS. The business’s revenue was up 10.9% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, analysts predict that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current fiscal year.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.